Arcturus Therapeutics Holdings (ARCT) Cash from Operations (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Cash from Operations data on file, last reported at 19441000.0 in Q1 2026.

• Quarterly Cash from Operations rose 44.67% year-over-year to 19441000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 58574000.0 (up 34.43% YoY) and the FY2025 annual result came in at 74271000.0, down 24.31% from the prior year.
• Cash from Operations retreated to 19441000.0 in Q1 2026, from 16227000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 160259000.0 in Q4 2022 to a low of 49039000.0 in Q1 2022.
• A 5-year average of 8209705.88 and a median of 19441000.0 in 2026 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations soared 477.11% — and 2025, when it sank 5613.73%.
• Tracing ARCT's Cash from Operations over 5 years: stood at 160259000.0 in 2022, then sank by 100.39% to 629000.0 in 2023, then soared by 54.85% to 284000.0 in 2024, then slumped by 5613.73% to 16227000.0 in 2025, then slipped by 19.81% to 19441000.0 in 2026.
• The last three Cash from Operations figures came in at 19441000.0 (Q1 2026), 16227000.0 (Q4 2025), and 17151000.0 (Q3 2025), per Business Quant data.